BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND NPM1, NPM, 4869, ENSG00000181163, P06748, B23, MGC104254 AND Prognosis
10 results:

  • 1. RNA expression of 6 genes from metastatic mucosal gastric cancer serves as the global prognostic marker for gastric cancer with functional validation.
    Suh YS; Lee J; George J; Seol D; Jeong K; Oh SY; Bang C; Jun Y; Kong SH; Lee HJ; Kim JI; Kim WH; Yang HK; Lee C
    Br J Cancer; 2024 May; 130(9):1571-1584. PubMed ID: 38467827
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Pumilio1 regulates npm3/npm1 axis to promote PD-L1-mediated immune escape in gastric cancer.
    Wang H; Zhou Z; Zhang J; Hao T; Wang P; Wu P; Su R; Yang H; Deng G; Chen S; Gu L; He Y; Zeng L; Zhang C; Yin S
    Cancer Lett; 2024 Jan; 581():216498. PubMed ID: 38029539
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinicopathological features of a rare cancer: Intrahepatic lymphoepithelioma-like cholangiocarcinoma with Epstein-Barr virus infection.
    Zheng L; Zhou N; Yang X; Wei Y; Yi C; Gou H
    Clin Res Hepatol Gastroenterol; 2023 Dec; 47(10):102244. PubMed ID: 37944749
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Identification and evaluation of novel serum autoantibody biomarkers for early diagnosis of gastric cancer and precancerous lesion.
    Zhu Q; He P; Zheng C; Chen Z; Qi S; Zhou D; Li Y; Ouyang Q; Zi H; Tang H; Xing J; Xie Y; Zhu S; Ren J; Huang J
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8369-8378. PubMed ID: 37079049
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. npm1 is a diagnostic and prognostic biomarker associated with the clinicopathological characteristics of gastric cancer.
    Guo CA; Su XL; Wang WJ; Xia TH; Cao XM; Yuan SB; Wang WA; Zhang A; Liu HB
    Neoplasma; 2022 Jul; 69(4):965-975. PubMed ID: 35723196
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Trastuzumab Specific Epitope Evaluation as a Predictive and Prognostic Biomarker in gastric cancer Patients.
    Koh J; Nam SK; Lee YW; Kim JW; Lee KW; Ock CY; Oh DY; Ahn SH; Kim HH; Kang KW; Kim WH; Lee HY; Lee HS
    Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31779184
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Using recursive partitioning approach to select tumor-associated antigens in immunodiagnosis of gastric adenocarcinoma.
    Qin J; Wang S; Shi J; Ma Y; Wang K; Ye H; Zhang X; Wang P; Wang X; Song C; Dai L; Wang K; Jiang B; Zhang J
    Cancer Sci; 2019 Jun; 110(6):1829-1841. PubMed ID: 30950146
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Both high expression of nucleophosmin/b23 and CRM1 predicts poorer prognosis in human gastric cancer.
    Zhou F; Chen E; You D; Song Y; Sun Z; Yue L
    APMIS; 2016 Dec; 124(12):1046-1053. PubMed ID: 27714846
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Impact of npm, TFF3 and TACC1 on the prognosis of patients with primary gastric cancer.
    Ding A; Zhao W; Shi X; Yao R; Zhou F; Yue L; Liu S; Qiu W
    PLoS One; 2013; 8(12):e82136. PubMed ID: 24358147
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinical significance of nucleophosmin/b23 and human epidermal growth factor receptor 2/neu expressions in gastric cancers.
    Zhou F; Qiu W; Sun L; Xiang J; Sun X; Sui A; Ding A; Yue L
    APMIS; 2013 Jul; 121(7):582-91. PubMed ID: 23489260
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.